BMI <25 kg/m 2 accounted for 49.0% (1,652/3,373) of the patients in this study, indicating an increasing trend in the number of non-obese patients with fatty liver in recent years.
← all excerpts
Impact of the FIB4 Index on Pre-sarcopenia in Patients with Metabolic-dysfunction Associated Steatotic Liver Disease.
1
—
—